Discover 1,440 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,440
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Moncton, Boston MA, Providence RI, Lake Success NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase3, Recruiting
The Effect of Epidural Fentanyl on Immune Function
for
Malignancy
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT01646775
Recruiting
Patient Specific Biomechanical Modeling of Abdominal Aortic Aneurysm to Improve Aortic Endovascular Repair
for
Aortic Aneurysm
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 0+
Code: NCT03481075
Recruiting
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
for
Biliary Tract Cancer
Location: New York NY, Montreal, Richmond VA, Toronto, Orlando FL,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06282575
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: St. John's, Halifax, Moncton, Portland ME, Boston MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: New Haven CT, Montreal, Baltimore MD, Durham NC,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase3, Recruiting
Impact of Intravenous Lidocaine During Colorectal Surgery on Pain and Immune Functions
for
Intravenous Lidocaine and Immunity
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal
Sex: All
Age: 18+
Code: NCT03410836
Recruiting
DOvEEgene Fleur: New Uterine Sampling Tool
for
Women With Suspected or Confirmed Gynecological Disease
Location: Montreal
Sponsor: McGill University
Sex: Female
Age: 18+
Code: NCT04258449
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Providence RI, New Haven CT, Quebec, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
Single Anastomosis Versus Standard Duodenal Switch
for
Obesity, Morbid Obesity
Location: Quebec City
Sponsor: Laval University
Sex: All
Age: 18 - 60
Code: NCT04767490
Recruiting
Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis
for
Scoliosis
Location: Montreal, San Diego CA
Sponsor: St. Justine's Hospital
Sex: All
Age: 10 - 15
Code: NCT02434003
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)